Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2014/10/005102
CTRI/2014/10/005102
Recruiting
未知

A Randomised, double blind, placebo controlled, three-way cross over study to evaluate the attention and cognitive function after single dose administration of Eszopiclone and Ramelteon using computerized stroop color word test in healthy human participants

izams Institute of Medical Sciences0 sites15 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
izams Institute of Medical Sciences
Enrollment
15
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
izams Institute of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •1\. Participants of either gender between 18\-45 years of age and BMI of 18\.5 to \< 25 kg/m2\.
  • •2\. Participants willing to sign informed consent.
  • •3\. Participants with normal physical, clinical examination and lab investigations.
  • •4\. Able to perform the test procedures, as per the protocol.
  • •5\. Participants with normal to corrected vision.
  • •6\. Able to read English words

Exclusion Criteria

  • •1\. H/o of psychiatric illiness, insomnia, use of any psychiatric medication.
  • •2\. H/o of drug dependence or any severe co\-morbid medical conditions.
  • •3\. H/o of serious adverse reactions or hypersensitivity to any drug.
  • •4\. Abnormality in lab investigations like complete blood picture, complete urine examination, liver function tests or renal function tests.
  • •5\. Participating in any drug trials/ research projects over the past 3 months.
  • •6\. Alcohol consumption 24 hrs before study day.
  • •7\. Tea / Coffee consumption or smoking 12 hrs before the study day.
  • •8\. Pregnant/breast feeding/ child bearing potential participants

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Bioavailability study in healthy volunteers.
CTRI/2023/04/051789SPECNOVA
Completed
Phase 2
Bioavailability study on Healthy subjects
CTRI/2024/04/066483SPECNOVA LLC18
Completed
Not Applicable
This is a randomized, double blind, placebo controlled, three group study in which the safety and efficacy of Curcuma caesia will be compared with Cyperus rotundus and Curcuma caesia for weight management in obese or overweight patients.Health Condition 1: null- Obese or overweight patientsHealth Condition 2: E66- Overweight and obesity
CTRI/2016/01/006487Sami Labs Limited60
Active, not recruiting
Not Applicable
A double blind, randomized, placebo-controlled, three-arm, phase II study to investigate the safety and efficacy of oral glycyrrhizin (Glycyron® tablets) for the treatment of gingivitis - Glycyropatients with gingivitisMedDRA version: 9.1Level: LLTClassification code 10018292Term: Gingivitis
EUCTR2008-008512-51-DEonepharm Research & Development GmbH
Unknown
Phase 3
A clinical trial to study the effect of cough mixture syrup of levosalbutamol, ambroxol and guaiphenesin in the treatment of patients suffering from productive cough associated with acute bronchitis.Health Condition 1: null- Productive Cough Associated with Acute Bronchitis
CTRI/2012/03/002477Glenmark Pharmaceuticals Ltd260